Queilitis actínica: protectores de rayos ultravioleta que previenen la progresión maligna. Reporte de un caso

Actinic cheilitis is considered a potentially malignant disorder, caused by excessive and prolonged exposure to the sun, affects the vermilion border and the labial semi-mucosa, being the loss of definition between the vermilion border and the cutaneous portion of the lip, a commonly found clinical...

Full description

Autores:
Madrid Bellio, Tomas
Jiménez Batista, Elio
Harris Ricardo, Jonathan
Carmona Lorduy, Martha
Tipo de recurso:
Fecha de publicación:
2020
Institución:
Universidad Santo Tomás
Repositorio:
Universidad Santo Tomás
Idioma:
spa
OAI Identifier:
oai:repository.usta.edu.co:11634/37346
Acceso en línea:
http://revistas.ustabuca.edu.co/index.php/USTASALUD_ODONTOLOGIA/article/view/2502
http://hdl.handle.net/11634/37346
Palabra clave:
Rights
License
Derechos de autor 2020 Ustasalud
Description
Summary:Actinic cheilitis is considered a potentially malignant disorder, caused by excessive and prolonged exposure to the sun, affects the vermilion border and the labial semi-mucosa, being the loss of definition between the vermilion border and the cutaneous portion of the lip, a commonly found clinical characteristic. It can present in a number of ways, including white plaque, erosion, and ulcers. The risk group is represented by people between the fourth and sixth decade of life, with Fitzpatrick phototype I and II, dedicated to working outdoors as farmers, laborers, fishermen, etc. Histologically, actinic cheilitis presents epithelial alterations that can give rise to squamous cell carcinoma, if diagnosis and treatment are not timely. The dentist is an important pillar in the early diagnosis and in the prevention of malignant transformation of this pathology, which is becoming more and more common. A case report of a male patient diagnosed with actinic cheilitis is presented, the clinical and histopathological aspects, risk factors and conservative management are described with topical use of lip balm with sun protection factors and periodic clinical evaluation, avoiding malignant progression.